A Major Role for Matrix Metalloproteinases in T Cell Injury in the Gut

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1582-1590

  Pender, Sylvia L F ^a,b   Tickle, Simon P ^c   Docherty, Andrew J P ^c   Howie, Duncan ^a   Wathen, Neville C ^b   MacDonald, Thomas T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; ENZYME INHIBITOR; ENZYME PRECURSOR; GLYCOPROTEIN; METALLOPROTEINASE; PEPTIDE; RECOMBINANT PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; BIOSYNTHESIS; CELL FREE SYSTEM; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; FETUS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE MUCOSA; METABOLISM; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PHYSIOLOGY; SMALL INTESTINE; T LYMPHOCYTE;

CELL LINE; CELL-FREE SYSTEM; COLLAGENASES; ENZYME ACTIVATION; ENZYME INHIBITORS; ENZYME PRECURSORS; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOPROTEINS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; METALLOENDOPEPTIDASES; ORGAN CULTURE TECHNIQUES; PEPTIDES; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0031568392     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Schuppan, D., and E. O. Riecken. 1990. Molecules of the extracellular matrix: potential role of collagens and glycoproteins in intestinal adaptation. Digestion 46:2.
2. Woessner, J. F., Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J. 5:2145.
3. Matrisian, L. M. 1992. The matrix-degrading metalloproteinases. Bioessays 14: 455.
4. Birkedal-Hansen, H., W. G. I. Moore, M. K. Bodden, L. J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J. A. Engler. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4:197.
5. Murphy, G., and J. J. Reynolds. 1993. Extracellular matrix degradation. In Connective Tissue and Its Heritable Disorders. P. M. Royce and B. Steinmann, eds. Wiley-Liss, Inc., New York, p. 287.
6. Dean, D. D., J. Martell-Pelletier, J.-P. Pelletier, D. S. Howell, and J. F. Woessner. 1989. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84:678.
7. Meikle, M. C., S. J. Atkinson, R. V. Ward, G. Murphy, and J. J. Reynolds. 1989. Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases. J. Periodont. Res. 24:207.
8. Banik, N. L. 1992. Pathogenesis of myelin breakdown in demyelinating disease: role of proteolytic enzymes. Crit. Rev. Neurobiol. 16:257.
9. Galis, Z. S., G. K. Sukhova, M. W. Lark, and P. Libby. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:2493.
10. MacDonald, T. T., and J. Spencer. 1992. Cell-mediated immune injury in the small intestine. Gastroenterol. Clin. North Am. 21:367.
11. Mullin, G. E., A. J. Lazenby, M. L. Harris, T. M. Bayless, and S. P. James. 1992. Increased interleukin-2 mRNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 102:1620.
12. Breese, E. J., C. P. Braegger, C. P. Corrigan, J. A. Walker-Smith, and T. T. MacDonald. 1993. Interleukin-2 and interferon-γ-secreting T cells in normal and diseased human intestinal mucosa. Immunology 78:127.
13. Lundin, K. E. A., H. Scott, T. Hansen, G. Paulsen, T. S. Halstensen, O. Fausa, E. Thorsby, and L. M. Sollid. 1993. Gliadin-specific, HLA-DQ (α1*0501, β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178:187.
14. Guy-Grand, D., and P. Vassalli. 1986. Gut injury in mouse graft-versus-host disease: study of its occurrence and mechanisms. J. Clin. Invest. 77:1584.
15. Cerf-Bensussan, N., N. Brousse, A. Jarry, O. Goulet, Y. Revillon, C. Ricour, and D. Guy-Grand. 1990. Role of in vivo activated T cells in the mechanisms of villous atrophy in humans: study of allograft rejection. Digestion 46:297.
16. Schreiber, S., A. Raedler, W. F. Stenson, and R. P. MacDermott. 1992. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol. Clin. North Am. 21:451.
17. Marsh, M. N. 1992. Mucosal pathology in gluten sensitivity. In Coeliac Disease. M. N. Marsh, ed. Blackwell Scientific Publications, Oxford, p. 136.
18. MacDonald, T. T., and J. M. Spencer. 1988. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J. Exp. Med. 167:1341.
19. + T cells and tissue damage in human small intestine induced by the bacterial superantigen, Staphylococcus aureus enterotoxin B. Eur. J. Immunol. 23:664.
20. Lionetti, P., E. Breese, C. P. Braegger, S. H. Murch, J. Taylor, and T. T. MacDonald. 1993. T cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine. Gastroenterology 105:373.
21. MacDonald, T. T., and J. Spencer. 1990. Ontogeny of human mucosal immunity. In Ontogeny of the Immune System of the Gut. T. T. MacDonald. ed. CRC Press, Boca Raton, p. 23.
22. Pender, S. L. F., P. Lionetti, S. H. Murch, N. Wathan, and T. T. MacDonald. 1996. Proteolytic degradation of intestinal mucosal extracellular matrix following lamina propria T cell activation. Gut 39:284.
23. Knight, C. G., F. Willenbrock, and G. Murphy. 1992. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296:263.
24. Chander, S. K., P. Antoniw, N. R. A. Beeley, B. Boyce, T. Crabbe, A. J. P. Docherty, J. Leonard, B. Mason, K. Millar, A. T. Millican, R. Morphy, A. Mountain, J. O'Connell, J. R. Porter, and N. Willmott. 1995. An in vivo model for screening peptidomimetic inhibitors of gelatinase A. J. Pharm. Sci. 84:404.
25. Cooksley, S., J. B. Hipkiss, S. P. Tickle, E. Holmes-Ivers, A. J. P. Docherty, G. Murphy, and A. D. G. Lawson. 1990. Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor or metalloproteinases (TIMP) and enzyme inhibitor complexes. Matrix 10:285.
26. Baker, T., S. P. Tickle, H. Wasan, A. J. P. Docherty, D. Isenberg, and J. Waxman. 1994. Serum metalloproteinases and their inhibitors: markers for malignant potential. Br. J. Cancer 70:506.
27. Klein, N. J., G. I. Shennan, R. S. Heyderman, and M. Levin. 1993. Detection of glycosaminoglycans on the surface of human umbilical vein endothelial cells using gold-conjugated poly-L-lysine with silver enhancement. Histochem. J. 25: 291.
28. Isaacson, P. G., and D. H. Wright. 1983. Immunocytochemistry of lympho reticular tumours. In Immunocytochemistry: Practical Applications in Pathology and Biology. J. M. Polak and S. van Noorden, eds. John Wright & Sons, Bristol, p. 249.
29. Murphy, L. D., C. E. Herzog, J. B. Rudick, A. T. Fojo, and S. E. Bates. 1990. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry 29:10351.
30. Onisto, M., S. Garbisa, C. Caenazzo, M. P. Freda, C. Di Francesco, D. Nitti, L. A. Liotta, and W. G. Stetler-Stevenson. 1993. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion. Diagn. Mol. Pathol. 2:74.
31. Jung, H. C., L. Eckmann, S.-K. Yang, A. Panja, J. Fierer, E. Morzycka-Wroblewska, and M. F. Kagnoff. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95:55.
32. Murch, S. H., T. T. MacDonald, J. A. Walker-Smith, M. Levin, P. Lionetti, and N. J. Klein. 1993. Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet 341:711.
33. Dayer, J. M., B. Beutler, and A. Cerami. 1985. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:2163.
34. Richman, P. I., R. Tilly, J. R. Jass, and W. F. Bodmer. 1987. Colonic pericrypt sheath cells: characterisation of cell type with new monoclonal antibody. J. Clin. Palhol. 40:593.
35. Monk, T., J. Spencer, N. Cerf-Bensussan, and T. T. MacDonald. 1988. Stimulation of mucosal T cells in situ with anti-CD3 antibody: location of the activated T cells and their distribution within the mucosal micro-environment. Clin. Exp. Immunol. 74:216.
36. MacDonald, T. T., A. Weinel, and J. Spencer. 1988. HLA-DR expression in human fetal intestinal epithelium. Gut 29:1342.
37. MacDonald, T. T., and J. Spencer. 1990. Ontogeny of the mucosal immune response. Springer Semin. Immunopathol. 12:129.
38. Kammer, G. M., A. I. Sapolsky, and C. J. Malemud. 1985. Secretion of an articular cartilage proteoglycan-degrading enzyme activity by murine T lymphocytes in vitro. J. Clin. Invest. 76:395.
39. Conca, W., and F. Willmroth. 1994. Human T lymphocytes express a member of the matrix metalloproteinase family. Arthritis Rheum. 37:951.
40. Leppert, D., E. Waubant, R. Galardy, N. W. Bunnett, and S. L. Hauser. 1995. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154:4379.
41. Welgus, H. G., E. J. Campbell, Z. Bar-Shavit, R. M. Senior, and S. L. Teitelbaum. 1985. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J. Clin. Invest. 76:219.
42. Garbisa, S., M. Ballin, D. Daga-Gordin, G. Fastelli, M. Naturale, A. Negro, G. Semenzato, and L. A. Liotta. 1986. Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J. Biol. Chem. 261:2369.
43. Zhou, H., E. J. Bernhard, F. E. Fox, and P. C. Billings. 1993. Induction of metalloproteinase activity in human T-lymphocytes. Biochim. Biophys. Acta 1177:174.
44. Nguyen, Q., G. Murphy, P. J. Roughley, and J. S. Mort. 1989. Degradation of proteoglycan aggregate by a cartilage metalloproteinase: evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ. Biochem. J. 259:61.
45. Gunja-Smith, Z., H. Nagase, and J. F. Woessner, Jr. 1989. Purification of the neutral proteoglycan-degrading metalloproteinase from human articular cartilage tissue and its identification as stromelysin matrix metalloproteinase-3. Biochem. J. 258:115.
46. Bejarno, P. A., M. E. Noelken, K. Suzuki, B. G. Hudson, and H. Nagase. 1988. Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin). Biochem. J. 256:413.
47. Hahn, U., A. Stallmach, E. G. Hahn, and E. O. Riecken. 1990. Basement membrane components are potent promoters of rat intestinal epithelial cell differentiation. Gastroenterology 93:322.
48. Olson, A. D., T. Pysher, and R. S. Bienkowski. 1991. Organisation of intestinal epithelial cells into multicellular structures requires laminin and functional actin filaments. Exp. Cell Res. 192:543.
49. Galloway, W. A., G. Murphy, J. D. Sandy, J. Gavrilovic, T. E. Cawston, and J. J. Reynolds. 1983. Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem. J. 209:741.
50. Murphy, G., M. I. Cockett, P. E. Stephens, B. J. Smith, and A. J. P. Docherty. 1987. Stromelysin is an activator of procollagenase, a study with natural and recombinant enzymes. Biochem. J. 248:265.
51. Suzuki, K., J. J. Enghild, T. Morodomi, G. Salvesen, and H. Nagase. 1990. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29:10261.
52. Saarialho-Kere, U. K., S. O. Kovacs, A. P. Pentland, J. E. Olerud, H. G. Welgus, and W. C. Parks. 1993. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J. Clin. Invest. 92:2858.
53. Cawston, T. E. 1986. Protein inhibitors of metalloproteinases. In Proteinase Inhibitors. A. J. Barrett and G. Salvesen eds. Elsevier. Amsterdam, p. 589.
54. Goetzl, E. J., M. J. Banda, and D. Leppert. 1996. Matrix metalloproteinases in immunity. J. Immunol. 156:1.
55. Romanic, A. M., and J. A. Madri. 1994. The induction of 72-KD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 125:1165.
56. Malik, N., B. W. Greenfield, A. F. Wahl, and P. A. Kiener. 1996. Activation of human monocytes through CD40 induces matrix metalloproteinases. J. Immunol. 156:3952.
57. Miltenburg, A. M. M., S. Lacraz, H. G. Welgus, and J.-M. Dayer. 1995. Immobilised anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J. Immunol. 154:2655.
58. Stetler-Stevenson, W. G. 1996. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am. J. Pathol. 148:1345.
59. Mahida, Y. R., K. Wu, and D. P. Jewell. 1989. Enhanced production of interleukin-1β by mononuclear cells isolated from mucosal biopsies of patients with active ulcerative colitis or Crohn's disease. Gut 30:835.
60. Youngman, K. R., P. L. Simon, G. A. West, F. Cominelli, D. Rachmilewitz, J. S. Klein, and C. Fiocchi. 1993. Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 104:749.
61. MaCabe, R. P., H. Secrist, M. Botney, M. Egan, and M. G. Peters. 1993. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin. Immunol. Immunopathol. 66:52.
62. Breese, E. J., C. A. Michie, S. W. Nicholls, S. H. Murch, C. B. Williams, P. Domizio, J. A. Walker-Smith, and T. T. MacDonald. 1994. Tumour necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106:1455.
63. Brenner, D. A., M. O'Hara, P. Angel, M. Chojkier, and M. Karin. 1989. Prolonged activation of jun and collagenase genes by tumor necrosis factor-α. Nature 337:661.
64. Gearing, A. J. H., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, T. M. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L. M. Wood, and K. Woolley. 1994. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370:555.
65. Braegger, C. P., S. Nicholls, S. H. Murch, S. Stephens, and T. T. MacDonald. 1992. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339:89.
66. Murch, S. H., S. P. Braegger, J. A. Walker-Smith, and T. T. MacDonald. 1993. Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease. Gut 34:1705.
67. Saarialho-Kere, U. K., M. Vaalamo, P. Puolakkainen, K. Airola, W. C. Parks, and M.-L. Karjalainen-Lindsberg. 1996. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am. J. Pathol. 148:519.
68. Bailey, C. J., R. M. Hembry, A. Alexander, M. H. Irving, M. E. Grant, and C. A. Shuttleworth. 1994. Distribution of the matrix metalloproteinases stromelysin, gelatinase A and B, and collagenase in Crohn's disease and normal intestine. J. Clin. Pathol. 47:113.
69. Anderson, I. A., M. A. Shipp, A. J. P. Docherty, and B. A. Teicher. 1996. Combined modality therapy with a cytotoxic agent and specific metalloproteinase inhibitor reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res. 56:715.